Proteins and methods for producing the proteins

Details Proteins and methods for producing the proteins Proteins and methods for producing the proteins

2005-02-15

2005-02-15

Ulm, John (Department: 1646)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C514S002600

Reexamination Certificate

active

06855808

ABSTRACT:
A protein which inhibits osteoclast differentiation and/or maturation and a method for producing the protein. The protein is produced by human embryonic lung fibroblasts and has a molecular weight of about 60 kD and about 120 kD under non-reducing conditions and about 60 kD under reducing conditions on SDS-polyacrylamide gel electrophoresis[[, respectively]]. The protein can be isolated and purified from the culture medium of fibroblasts. Furthermore, the protein can be produced by gene engineering. The present invention includes cDNA for producing the protein by gene engineering, antibodies having specific affinity for the protein or a method for determining protein concentration using these antibodies.

REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 4710473 (1987-12-01), Morris
patent: 4959314 (1990-09-01), Mark et al.
patent: 5118667 (1992-06-01), Adams et al.
patent: 5393739 (1995-02-01), Bentz et al.
patent: 5447851 (1995-09-01), Beutler et al.
patent: 5457035 (1995-10-01), Baum et al.
patent: 5578569 (1996-11-01), Tam
patent: 5585479 (1996-12-01), Hoke et al.
patent: 5599708 (1997-02-01), Mundy et al.
patent: 5658756 (1997-08-01), Rodan et al.
patent: 5843678 (1998-12-01), Boyle
patent: 5843901 (1998-12-01), Roeske
patent: 5985832 (1999-11-01), Roodman et al.
patent: 6015938 (2000-01-01), Boyle et al.
patent: 6017729 (2000-01-01), Anderson et al.
patent: 6087555 (2000-07-01), Dunstan et al.
patent: 6284485 (2001-09-01), Boyle et al.
patent: 6284728 (2001-09-01), Boyle et al.
patent: 6284740 (2001-09-01), Boyle et al.
patent: 6288032 (2001-09-01), Boyle et al.
patent: 6316408 (2001-11-01), Boyle
patent: 6369027 (2002-04-01), Boyle et al.
patent: 6419929 (2002-07-01), Anderson
patent: 0514130 (1992-11-01), None
patent: 0514130 (1992-11-01), None
patent: 0526905 (1993-02-01), None
patent: 0526905 (1993-02-01), None
patent: 0727211 (1996-08-01), None
patent: 0874045 (1998-10-01), None
patent: 0911342 (1999-04-01), None
patent: 330400 (1999-05-01), None
patent: 8600922 (1986-02-01), None
patent: 9014363 (1990-11-01), None
patent: 9312227 (1993-06-01), None
patent: 9321946 (1993-11-01), None
patent: 9511308 (1995-04-01), None
patent: 9626271 (1996-08-01), None
patent: 9628546 (1996-09-01), None
patent: 9700317 (1997-01-01), None
patent: 9700318 (1997-01-01), None
patent: 9723614 (1997-07-01), None
patent: 9807840 (1998-02-01), None
patent: 9825958 (1998-06-01), None
patent: 9828424 (1998-07-01), None
patent: 9828426 (1998-07-01), None
patent: 9846751 (1998-10-01), None
patent: 9849305 (1998-11-01), None
patent: 9919468 (1999-04-01), None
patent: 9953942 (1999-10-01), None
patent: 9658674 (1999-11-01), None
patent: 9958674 (1999-11-01), None
patent: 0103719 (2001-01-01), None
patent: 0103719 (2001-01-01), None
patent: 0117543 (2001-03-01), None
patent: 0117543 (2001-03-01), None
patent: 0118203 (2001-03-01), None
Adams et al., “Complementary DNA Sequencing: Expressed Sequence Tags and Human Genome Project”,Science, 252:1651-1656 (1991).
Anderson et al., “A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function”,Nature, 390:175-179 (1997).
Banks et al., “Effect of degenerative spinal annd aortic calcification on bone density measurements in post-menopausal women: links between osteoporosis and cardiovascular disease?”,European Journal of Clinical Investigation, 24(12):813-817 (1994).
Banner et al., “Crystal Structure of the Soluble Human 55 kd TNF Receptor-Human TNFβ Complex: Implications for TNF Receptor Activation”,Cell, 73(3):431-445 (1993).
Bennett, C.F., “Antisense Research”,Science, 271:434 (1996).
Beutler and van Huffel, “Unraveling Function in the TNF Ligand and Receptor Families”,Science, 264:667-668 (1994).
Beutler and Cerami, “Tumor Necrosis, Cachexia, Shock, and Inflammation: a Common Mediator”,Annual Review of Biochemistry, 57:505-518 (1988).
Boyce et al., “Effects of Interleukin-1 on Bone Turnover in Normal Mice”,Endocrinology, 125(3):1142-1150 (1989).
Bradley and Robertson, “Embryo-Derived Stem Cells: a Tool for Elucidating the Development Genetics of the Mouse”,Current Topics in Developmental Biology, 20:357-371 (1986).
Brinster et al., “Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs”,Proceedings of the National Academy of Sciences of USA, 82:4438-4442 (1985).
Bucay et al., “osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification”,Genes and Development, 12(9):1260-1268 (1998).
Capon et al., “Designing CD4 immunoadhesins for AIDS therapy”,Nature, 337(6207):525-531 (1989).
Cappecchi, M. R., “Altering the Genome by Homologous Recombination”,Science, 244:1288-1292 (1989).
Chambers et al., “Generation of osteoclast-inductive and osteoclastogenic cell lines from theH-2KbtsA58transgenic mouse”,Proceedings of the National Academy of Sciences of USA, 90:5578-5582 (1993).
Charreau et al., “Transgenesis in rats: technical aspects and models”,Transgenic Research, 5(4):223-234 (1996).
Chen et al., “Mapping the Domain(s) Critical for the Binding of Human Tumor Necrosis Factor-α to Its Two Receptors”,Journal of Biological Chemistry, 270(6):2874-2878 (1995).
Chenu et al., “Transforming growth factor β inhibits formation of osteoclast-like cells in long-term human marrow cells”,Proceedings of the Nationa Academy of Sciences of USA, 85(15):5683-5687 (1988).
Chomczynski and Sacchi, “Single-Step Method of RNA Isolation by acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction”,Analytical Biochemistry, 162(1):156-159 (1987).
Culver and Blaese, “Gene therapy for cancer”,Trends in Genetics, 10(5):174-178 (1994).
Database EMEST16, EMBL Database Accession No. AA170348.
Database GenEMBL, EMBL Accession No. AF019048.
DeClerck et al., “Inhibition of Autoproteolytic Activation of Interstitial Procollagenes by Recombinant Metalloproteinase Inhibitor MI/TIMP-2”,Journal of Biological Chemistry, 266(6):3893-3899 (1991).
Demer, L. L., “A Skeleton in the Atherosclerosis Closet”,Circulation, 92(8):2029-2032 (1995).
Ebi et al., “Mechanism of Mast Cell Deficiency in Mutant Mice ofmi/miGenotype: An Analysis by Co-Culture of Mast Cells and Fibroblasts”,Blood, 75(6):1247-1251 (1990).
Efrat, S., “Prospects for gene therapy of insulin-dependent diabetes mellitus”,Diabetologia, 41(12):1401-1409 (1998).
Ellison et al., “The nucleotide sequence of a human immunoglobulin Cγ1gene”,Nucleic Acids Research, 10(13):4071-4079 (1982).
Engels and Uhlmann, “Gene Synthesis”,Angew. Chem. Int. Ed. Engl., 28:716-734 (1989).
Fawthrop et al., “The Effect of Transforming Growth Factor β on the Plasminogen Activator Activity of Normal Human Osteoblast-like Cells and a Human Osteosarcoma Cell Line MG-63”,Journal of Bone and Mineral Research, 7(12):1363-1371 (1992).
Fenton et al., “Long-Term Culture of Disaggregated RAt Osteoclasts: Inhibition of Bone Resorption and Reduction of Osteoclast-Like Cell Number by Calcitonin and PTHrP[107-139]”,Journal of Cellular Physiology, 155:1-7 (1993).
Fisher et al., “Dominant Interfering Fas Gene Mutations Impair Apoptosis in a Human Autoimmune Lymphoproliferative Syndrome”,Cell, 81(6):935-946 (1995).
Galli-Taliadoros et al., “Gene knock-out technology: a methodological overview for the interested novice”,Journal of Immunological Methods, 181(1):1-15 (1995).
George et al., “Current Methods in Sequence Comparison and Analysis”,Macromolecular Sequencing and Synthesis Selected Methods and Applications, pp. 127-149 (1988).
Goeddel, D. V., “Systems for Heterologous Gene Expression”,Methods in Enzymology, 185:3-7 (1990).
Goeddel et al., “Tumor Necrosis Factors: Gene Structure and Biological Activiti

Affiliated with

Also associated with

Rating

Proteins and methods for producing the proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Proteins and methods for producing the proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteins and methods for producing the proteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3508261